ACXPAcurx Pharmaceuticals, Inc.

Nasdaq www.acurxpharma.com


$ 2.38 $ -0.06 (-2.46 %)    

Thursday, 28-Mar-2024 10:27:38 EDT
QQQ $ 444.76 $ 0.12 (0.03 %)
DIA $ 397.30 $ -0.88 (-0.22 %)
SPY $ 523.31 $ 0.06 (0.01 %)
TLT $ 94.68 $ 0.22 (0.23 %)
GLD $ 204.64 $ -0.31 (-0.15 %)
$ 2.33
$ 2.44
$ 0.00 x 0
$ 0.00 x 0
$ 2.38 - $ 2.44
$ 1.17 - $ 8.82
86,853
na
29.52M
$ 0.00
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-15-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-11-2023 06-30-2023 10-Q
4 05-12-2023 03-31-2023 10-Q
5 03-15-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-12-2022 06-30-2022 10-Q
8 05-10-2022 03-31-2022 10-Q
9 03-16-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-13-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-acurx-pharmaceuticals-lowers-price-target-to-12

HC Wainwright & Co. analyst Ed Arce maintains Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and lowers the price target...

 acurx-pharmaceuticals-q4-eps-037-misses-026-estimate

Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate ...

 earnings-scheduled-for-march-18-2024

Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter.

 hc-wainwright--co-reiterates-buy-on-acurx-pharmaceuticals-maintains-14-price-target

HC Wainwright & Co. analyst Ed Arce reiterates Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and maintains $14 price ta...

 acurx-reports-extended-clinical-cure-data-for-ibezapolstat-its-lead-antibiotic-candidate-from-recently-completed-phase-2b-clinical-trial-in-patients-with-cdi

This exploratory endpoint showed that 12 patients who agreed to be followed up to three months following Clinical Cure of their...

 why-airspan-networks-shares-are-trading-higher-by-over-380-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announ...

 why-is-antibiotic-player-acurx-pharmaceuticals-stock-trading-lower-today

Acurx Pharmaceuticals' ibezapolstat outperforms vancomycin with a 94% eradication rate. Stay tuned for Q1 2024 updates on E...

 hc-wainwright--co-maintains-buy-on-acurx-pharmaceuticals-raises-price-target-to-14

HC Wainwright & Co. analyst Ed Arce maintains Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and raises the price target...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION